Ferric Ammonium Citrate Effervescent Granules
Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resonance contrast agent/media approved by NMPA in the market, which is a safe and effective double contrast media products with the advantages of convenient use and good safety. This ammonium iron citratecan significantly improve the images quality of MRCP and MRU, and can also be used as a positive contrast agent for the digestive tract.
Product name: Ferric Ammonium Citrate Effervescent Granules
Type: Oral MRI Contrast Media
Ingredients: Ferric ammonium citrate
Specification: 3g: 0.6g（Fe 129mg), 6g: 1.2g（Fe 258mg）
Posology and method of administration: Oral
Adverse reactions: Foreign clinical data reported that after using this MRI contrast medium, 0.1-0.5% of patients has diarrhea, 0.1% had nausea, vomiting, and decreased appetite, and a very small number of patients has stomach discomfort and bloating. All the above symptoms can be eliminated by themselves.
Shelf life: 24 months
Indications of Ferric Ammonium Citrate Effervescent Granules
Used for magnetic resonance abdominal imaging, angiography of the digestive tract (stomach duodenum and jejunum).
Precautions of Ferric Ammonium Citrate Effervescent Granules
Use with caution in the following patients: patients with the gastrointestinal tract such as peptic ulcer, ulcerative colitis, local enteritis, etc.
The stool appearing black after administration is a normal phenomenon.
During the ferric ammonium citrate uses, false-positive for occult blood may occur.
BeiluPharma is open to collaborating with any interested and relevant parties worldwide and we will continue to strive to provide high-quality products at a competitive price.
在线联系供应商
Other supplier products
 |
CT/X-Ray Contrast Media | The main component of CT/X-ray Contrast Media is iodine. The Iodinated Contrast Media is a colorless, transparent, slightly viscous liquid. At pres... |
 |
Repaglinide Tablets | Repaglinide tabletsare non-sulfonylurea insulin secretion agents and are used to treat patients with type 2 diabetes. Repaglinide tablets were list... |
 |
Contrast Media | Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutic... |
 |
Gadopentetate Dimeglumine Injection/API | Since Gadopentetate DimeglumineInjection was launched in 1992 by BeiluPharma in China, it was highly recommended and accepted by the radiologist, a... |
 |
Anti-Anxiety Drug | Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutic... |
